Experienced in Porphyria

Dr. Alina Basnet

Hematology | Oncology
Guthrie Medical Group PC
34 W Main St, 
Cortland, NY 
Clinical Trials:Currently Recruiting for 3 Trials
Accepting New Patients
Experienced in Porphyria
Guthrie Medical Group PC
34 W Main St, 
Cortland, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Alina Basnet is a Hematologist and an Oncologist in Cortland, New York. Dr. Basnet is rated as an Experienced provider by MediFind in the treatment of Porphyria. Her top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Urothelial Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Basnet is currently accepting new patients.

Her clinical research consists of co-authoring 73 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology
Oncology
Licenses
Internal Medicine in IL
Hospital Affiliations
Guthrie Cortland Regional Medical Center
Conemaugh Memorial Medical Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Capital District Physicians Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

GUTHRIE MEDICAL GROUP PC
34 W Main St, Cortland, NY 13045

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC)
A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC)
Enrollment Status: Recruiting
Publish Date: December 17, 2025
Intervention Type: Procedure, Biological, Drug
Study Drugs: Cabozantinib, Ipilimumab, Nivolumab
Study Phase: Phase 2
Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events
Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events
Enrollment Status: Recruiting
Publish Date: December 12, 2025
Intervention Type: Procedure, Other
A Phase II Study of Gemcitabine Plus Cisplatin Chemotherapy in Patients With Muscle-invasive Bladder Cancer With Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations
A Phase II Study of Gemcitabine Plus Cisplatin Chemotherapy in Patients With Muscle-invasive Bladder Cancer With Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations
Enrollment Status: Recruiting
Publish Date: December 11, 2025
Intervention Type: Procedure, Drug, Biological, Other
Study Drugs: Gemcitabine, Cisplatin, Pegfilgrastim
Study Phase: Phase 2
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: November 20, 2025
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Atezolizumab, Cisplatin, Fluorouracil, Gemcitabine, Mitomycin C
Study Phase: Phase 3
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Other, Biological, Procedure
Study Drug: Pembrolizumab
Study Phase: Phase 3
Duration of Immune Checkpoint Therapy in Locally Advanced or Metastatic Urothelial Carcinoma: a Randomized Phase 3 Non-Inferiority Trial (IMAGINE)
Duration of Immune Checkpoint Therapy in Locally Advanced or Metastatic Urothelial Carcinoma: a Randomized Phase 3 Non-Inferiority Trial (IMAGINE)
Enrollment Status: Active_not_recruiting
Publish Date: January 15, 2025
Intervention Type: Drug
Study Drugs: Pembrolizumab, Nivolumab, Atezolizumab, Durvalumab, Avelumab
Study Phase: Phase 3
View 3 Less Clinical Trials

73 Total Publications

Search for the Rare Decay D^{0}→μ^{+}μ^{-} in Proton-Proton Collisions at sqrt[s]=13.6  TeV.
Search for the Rare Decay D^{0}→μ^{+}μ^{-} in Proton-Proton Collisions at sqrt[s]=13.6  TeV.
Journal: Physical review letters
Published: June 06, 2025
Similar Doctors
Advanced in Porphyria
Dr. Timothy E. Bael
Hematology Oncology | Hematology | Oncology
Advanced in Porphyria
Dr. Timothy E. Bael
Hematology Oncology | Hematology | Oncology

Cayuga Medical Associates PC

310 Taughannock Blvd, Suite 4, 
Ithaca, NY 
 (18.3 miles away)
607-269-0100
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Timothy Bael is a Hematologist Oncology specialist and a Hematologist in Ithaca, New York. Dr. Bael is rated as a Distinguished provider by MediFind in the treatment of Porphyria. His top areas of expertise are Primary Lymphoma of the Brain, Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Bone Marrow Aspiration, and Endoscopy.

Advanced in Porphyria
Dr. Zheng K. Zhou
Hematology Oncology | Hematology | Oncology
Advanced in Porphyria
Dr. Zheng K. Zhou
Hematology Oncology | Hematology | Oncology

Department Of Medicine Medical Serv Grp At Suny Hlth Sci Ctr Syr In

750 E Adams St, 
Syracuse, NY 
 (32.5 miles away)
315-464-5240
Languages Spoken:
English
See accepted insurances

Zheng Zhou is a Hematologist Oncology specialist and a Hematologist in Syracuse, New York. Dr. Zhou is rated as an Advanced provider by MediFind in the treatment of Porphyria. His top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Bernard Poiesz
Experienced in Porphyria
Dr. Bernard Poiesz
Hematology | Oncology
Experienced in Porphyria
Dr. Bernard Poiesz
Hematology | Oncology

Auburn Community Hospital

17 Lansing St, 
Auburn, NY 
 (31.4 miles away)
315-255-7142
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Bernard Poiesz is a Hematologist and an Oncologist in Auburn, New York. Dr. Poiesz is rated as a Distinguished provider by MediFind in the treatment of Porphyria. His top areas of expertise are Cutaneous T-Cell Lymphoma (CTCL), Small Lymphocytic Lymphoma (SLL), Acute Myeloblastic Leukemia with Maturation, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Basnet's expertise for a condition
ConditionClose
    View All 29 Advanced Conditions
    View All 51 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile